SCHEMBL19231900

SCHEMBL19231900

Cc1nc2ncc(-c3nc(Nc4ccc(CN5C[C@@H]6C[C@H]5CN6)cn4)ncc3F)cc2n1C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK6 Q00534 16/20 0.54
CDK4 P11802 15/20 0.54
CCND1 P24385 8/20 0.54
CDK1 P06493 7/20 0.54
CDK2 P24941 6/20 0.54
CCNA2 P20248 4/20 0.54
CCND3 P30281 4/20 0.54
CCNB1 P14635 4/20 0.54
CCNE1 P24864 3/20 0.54
DYRK2 Q92630 2/20 0.54
CDK7 P50613 2/20 0.54
CDK9 P50750 2/20 0.54
CIT O14578 1/20 0.54
GAK O14976 1/20 0.54
DYRK3 O43781 1/20 0.54
CCNT1 O60563 1/20 0.54
STK16 O75716 1/20 0.54
CCNK O75909 1/20 0.54
STK10 O94804 1/20 0.54
PRKD3 O94806 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17489286 0.90 CDK4 (0.68) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231729 0.87 CDK6 (0.55) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231896 0.87 CDK6 (0.55) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231738 0.85 CDK6 (0.61) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231760 0.84 CDK6 (0.62) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231759 0.84 CDK6 (0.57) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19209791 0.84 CDK6 (0.60) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231755 0.83 CDK6 (0.61) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19231756 0.83 CDK6 (0.57) CDK6CDK4CCND1CDK1CDK2
SCHEMBL19209847 0.82 CDK6 (0.68) CDK6CDK4CCND1CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017133701-A1 CERTAIN PROTEIN KINASE INHIBITORS SHANGHAI FOCHON PHARMACEUTICAL CO., LTD. (CN) 2017-08-10 WO disclosed